A9F-25732-94684
4 vaccinations
4 coded responses
32 check-ins
4 free-text entries
2 call cases
- Sex
- —
- Age at first dose
- 31-35
- ZIP prefix
- 441 / OH
- Registered
- 2021-02-11
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-11
Registered in v-safe
-
2021-02-11
Dose 1 — Moderna
-
2021-02-11
Health check-in — day 0, dose 1Feeling: Good · Site: Pain · None · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-12
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-13
Health check-in — days 1–6 daily, dose 1Feeling: Good · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-02-14
- 2021-02-15
- 2021-02-16
- 2021-02-17
- 2021-02-18
- 2021-02-25
-
2021-03-04
Survey response — day 21, dose 1MedDRA: Cough, Nasal discomfort, Oropharyngeal pain, Upper-airway cough syndrome — Feeling: Good · Be unable to do your normal daily activitiesFree text: Post nasal drip, irritation, cough, sore throatMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-11
Dose 2 — Moderna
- 2021-03-11
-
2021-03-12
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-03-13
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-14
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to workAdult check-in
-
2021-03-15
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-03-16
-
2021-03-17
Health check-in — days 1–6 daily, dose 2Feeling: Good · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-03-18
- 2021-03-25
- 2021-04-01
- 2021-04-08
- 2021-04-15
- 2021-04-22
- 2021-06-10
-
2021-09-09
Survey response — 6 months, dose 2MedDRA: Respiratory tract congestion, Rhinorrhoea — Feeling: GoodFree text: Sniffles. Congestion.MedDRA releases: 2024-11 · check-in free text available
-
2021-11-09
Dose 3 — Moderna
- 2022-03-11
-
2022-05-10
Survey response — 6 months, dose 3MedDRA: Ageusia, Anosmia, Cough, Dyspnoea, Oropharyngeal pain, Respiratory tract congestion, Rhinorrhoea — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Sore throat. Loss of taste and smell. Congestion. Shortness of breath. Runny nose. Cough.MedDRA releases: 2024-11 · check-in free text available
-
2022-05-10
Report sent to call center — 6 months, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-05-11
-
2022-09-12
Dose 4 — Moderna
- 2022-10-14
- 2022-10-17
- 2022-10-24
-
2022-12-13
Survey response — 3 months, dose 4MedDRA: Ear infection — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Ear infectionMedDRA releases: 2024-11 · check-in free text available
-
2022-12-13
Report sent to call center — 3 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-12-15
Call successfulNot applicable - Accidental Reporting
-
2022-12-15
Call successfulNot applicable - Accidental Reporting
- 2023-03-14
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-11 | Moderna | |
| 2 | 2021-03-11 | Moderna | |
| 3 | 2021-11-09 | Moderna | No |
| 4 | 2022-09-12 | Moderna | No |
Call center
2 call center cases
2 successful
Free text
Release 5 — day 21, dose 1
Symptoms: Post nasal drip, irritation, cough, sore throat
Release 9 — 6 months, dose 2
Symptoms: Sniffles. Congestion.
Release 11 — 6 months, dose 3
Symptoms: Sore throat. Loss of taste and smell. Congestion. Shortness of breath. Runny nose. Cough.
Release 12 — 3 months, dose 4
Symptoms: Ear infection
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Ageusia | · | · | ✓ |
| SD | Anosmia | · | · | ✓ |
| SD | Cough | ✓ | ✓ | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Ear infection | · | · | ✓ |
| SD | Nasal discomfort | ✓ | ✓ | ✓ |
| SD | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Upper-airway cough syndrome | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release